Approach to diagnosis and management of childhood attention deficit hyperactivity disorder.

OBJECTIVE: To provide primary care clinicians with an approach to the diagnosis and management of attention deficit hyperactivity disorder (ADHD) by reviewing and summarizing the relevant practice guidelines and recent evidence from the literature. SOURCES OF INFORMATION: Published guidelines on the management of ADHD were reviewed. A PubMed search was conducted with the MeSH terms attention deficit disorder and family practice. Results were limited to articles published in English within the past 15 years. MAIN MESSAGE: Attention deficit hyperactivity disorder is a common neurodevelopmental disorder. Guidelines agree that diagnosis and management of ADHD is appropriate within primary care. Attention deficit hyperactivity disorder is diagnosed by applying the criteria defined within the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, and is supplemented by validated rating scales. Behavioural management is first-line management in all patients, and stimulant medications are first-line management in patients 6 years of age and older. The Canadian ADHD Resource Alliance provides free resources to help clinicians care for patients with ADHD. CONCLUSION: Most patients with ADHD can be managed by family physicians. It is a chronic condition that requires ongoing follow-up. Attention deficit hyperactivity disorder that is complicated by comorbidities might require referral to a specialist.

Approche diagnostique et de prise en charge du trouble déficitaire de l'attention avec hyperactivité chez l'enfant.

OBJECTIF: Proposer aux médecins de première ligne une approche diagnostique et de prise en charge du trouble déficitaire de l'attention avec hyperactivité (TDAH) en examinant et en résumant les lignes directrices pertinentes de pratique clinique et les données récentes relevées dans les publications scientifiques. SOURCES D'INFORMATION: Nous avons examiné les lignes directrices publiées sur la prise en charge du TDAH. Une recherche a été réalisée dans PubMed à l'aide des motsclés anglais attention deficit disorder et family practice. Les résultats étaient limités aux articles publiés en anglais au cours des 15 dernières années. MESSAGE PRINCIPAL: Le trouble déficitaire de l'attention avec hyperactivité est un trouble neurodéveloppemental courant. Les lignes directrices s'entendent pour dire qu'il est approprié de poser un diagnostic et d'entreprendre la prise en charge du TDAH en première ligne. Le trouble déficitaire de l'attention avec hyperactivité est diagnostiqué en appliquant les critères définis dans le Manuel diagnostique et statistique des troubles mentaux, 5e édition, qu'on complète avec les scores aux échelles validées. La prise en charge comportementale est l'intervention de première intention chez tous les patients, et les stimulants sont l'intervention de première intention chez les patients de 6 ans et plus. La Canadian ADHD Resource Alliance fournit gratuitement des ressources aux médecins pour les aider à soigner les patients atteints du TDAH. CONCLUSION: La plupart des patients atteints du TDAH peuvent être pris en charge par les médecins de famille. Le TDAH est une affection chronique qui exige un suivi continuel. Les cas de trouble déficitaire de l'attention avec hyperactivité qui sont compliqués par des comorbidités pourraient nécessiter une recommandation à un spécialiste.

Undiagnosed attention deficit/hyperactivity disorder (ADHD) among unionized drivers in Ghana: Public health and policy implications.

Road traffic accidents (RTA) are among the leading causes of mortality in sub-Saharan Africa. Many males that drop out of school in Ghana, a population at risk for attention-deficit hyperactivity disorder (ADHD), find employment by joining driver's unions. Moreover, the vehicles of Ghanaian unionized drivers are over-represented in fatal road accidents. Untreated ADHD has been linked with higher rates of RTAs. The objectives of this cross-sectional analysis is to determine the following among unionized drivers in Ghana: 1) the prevalence of ADHD, and 2) the association between self-reported ADHD risk and driving behavior. Data comes from participants' responses (200 unionized drivers and 171 community controls) to a 6-item ADHD Self - Report Scale (ASRS), the Driving Behavior Survey (DBS), and a culturally adapted version of the Jerome Driving Questionnaire (JDQ-GH). The self-reported prevalence of ADHD was 17.6% for the unionized drivers and 7.8% for the control group (χ2=7.7, df=1, p=0.006). Also, ADHD drivers endorsed that they were more likely to pay bribes to police and having worse driving behaviors across among both unionized drivers and controls. Study findings suggest that increased awareness of ADHD and possible screening of drivers for ADHD with subsequent evaluation and treatment may result in prevention of vehicle accidents.

Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia.

A case of a 62-year-old woman presenting with a 20-year history of vulvodynia previously unresponsive to medical treatment is described. The epidemiology, phenomenology and medical management of vulvodynia is reviewed. The case presentation illustrates the role of pregabalin in successful medical management of this chronic pain disorder, as well as the management of common psychiatric morbidities associated with this condition.

Attention-deficit/hyperactivity disorder (ADHD) and driving risk: a review of the literature and a methodological critique.

This article examines the literature on attention-deficit/hyperactivity disorder (ADHD) and unintentional driving injury. This literature has emerged over the last decade as part of the burgeoning epidemic of road traffic death and injury, which is the number-one cause of death among young adults in North America. The available literature on observational outcome studies and experimental pharmacologic interventions is critically reviewed. A meta-analysis of behavioral outcomes and a review of effect size of pharmacologic studies are presented. Current data support the utility of stimulant medication in improving driving performance in younger ADHD drivers. A conceptual model of risk factors in young ADHD drivers is offered. The current state of screening instruments for identifying high-risk subjects within this clinical group is summarized along with a final section on emerging trends and future prospects for intervention.

What we know about ADHD and driving risk: a literature review, meta-analysis and critique.

INTRODUCTION: This article examines the literature on ADHD and unintentional driving injury. This literature has emerged over the last decade as part of the burgeoning epidemic of road traffic death and injury which is the number one cause of death in young adults in North America. METHODS: The available literature on observational outcome studies and experimental pharmacological interventions is critically reviewed. A meta-analysis of behavioral outcomes and a review of effect size of pharmacological studies are presented. RESULTS: Current data support the utility of stimulant medication in improving driving performance in younger ADHD drivers. A conceptual model of risk factors in young ADHD drivers is offered. CONCLUSION: The current state of screening instruments for identifying high risk subjects within this clinical group is summarized along with a final section on emerging trends and future prospects for intervention.